Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma.

Li, Jiuzhen; Lin, Xuefeng; Li, Xin; Zhang, Weiran; Sun, Daqiang

Li, Jiuzhen; Lin, Xuefeng; Li, Xin; Zhang, Weiran; Sun, Daqiang.

Afiliação

Li J; Graduate School, Tianjin Medical University, Tianjin, China.
Lin X; Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China.
Li X; Tianjin Medical College, Tianjin, China.
Zhang W; Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China.
Sun D; Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China.

Ann Transl Med ; 10(4): 187, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35280419

Palavras-chave

EGFR mutation; Resectable stage IIIA lung adenocarcinoma; gene detection; prognostic factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google